DK2139892T3 - Substituerede pyrimidodiazepiner nyttige som PLK1-inhibitorer - Google Patents

Substituerede pyrimidodiazepiner nyttige som PLK1-inhibitorer

Info

Publication number
DK2139892T3
DK2139892T3 DK08717594.9T DK08717594T DK2139892T3 DK 2139892 T3 DK2139892 T3 DK 2139892T3 DK 08717594 T DK08717594 T DK 08717594T DK 2139892 T3 DK2139892 T3 DK 2139892T3
Authority
DK
Denmark
Prior art keywords
pyrimidodiazepines
substituted
useful
plk1 inhibitors
plk1
Prior art date
Application number
DK08717594.9T
Other languages
English (en)
Inventor
Jianping Cai
Shaoqing Chen
Xin-Jie Chu
Kang Le
Kin-Chun Thomas Luk
Peter Michael Wovkulich
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39415299&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2139892(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Application granted granted Critical
Publication of DK2139892T3 publication Critical patent/DK2139892T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/18—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK08717594.9T 2007-03-22 2008-03-11 Substituerede pyrimidodiazepiner nyttige som PLK1-inhibitorer DK2139892T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91935807P 2007-03-22 2007-03-22
PCT/EP2008/052847 WO2008113711A1 (en) 2007-03-22 2008-03-11 Substituted pyrimidodiazepines useful as plk1 inhibitors

Publications (1)

Publication Number Publication Date
DK2139892T3 true DK2139892T3 (da) 2011-12-12

Family

ID=39415299

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08717594.9T DK2139892T3 (da) 2007-03-22 2008-03-11 Substituerede pyrimidodiazepiner nyttige som PLK1-inhibitorer

Country Status (23)

Country Link
US (1) US7517873B2 (da)
EP (1) EP2139892B1 (da)
JP (1) JP5087640B2 (da)
KR (1) KR101157848B1 (da)
CN (2) CN102746175B (da)
AR (1) AR065794A1 (da)
AT (1) ATE524472T1 (da)
AU (1) AU2008228303B2 (da)
BR (1) BRPI0809088A2 (da)
CA (1) CA2680757A1 (da)
CL (1) CL2008000785A1 (da)
CY (1) CY1112102T1 (da)
DK (1) DK2139892T3 (da)
ES (1) ES2371832T3 (da)
HR (1) HRP20110807T1 (da)
IL (1) IL200617A (da)
MX (1) MX2009010034A (da)
PE (1) PE20120495A1 (da)
PL (1) PL2139892T3 (da)
PT (1) PT2139892E (da)
SI (1) SI2139892T1 (da)
TW (1) TWI363629B (da)
WO (1) WO2008113711A1 (da)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2695753A1 (en) * 2007-08-15 2009-02-19 Vertex Pharmaceuticals Incorporated Compounds useful as protein kinases inhibitors
US20110201818A1 (en) * 2007-09-25 2011-08-18 Takeda Pharmaceutical Company Limited Polo-like kinase inhibitors
US8563542B2 (en) 2007-09-28 2013-10-22 Cyclacel Limited Pyrimidine derivatives as protein kinase inhibitors
WO2009067547A1 (en) * 2007-11-19 2009-05-28 Takeda Pharmaceutical Company Limited Polo-like kinase inhibitors
TWI490214B (zh) 2008-05-30 2015-07-01 艾德克 上野股份有限公司 苯或噻吩衍生物及該等作為ｖａｐ－１抑制劑之用途
EP2303889A1 (en) 2008-06-18 2011-04-06 F. Hoffmann-La Roche AG Halo-substituted pyrimidodiazepines as plkl inhibitors
AU2009333559B2 (en) 2008-12-09 2015-03-12 Gilead Sciences, Inc. Modulators of toll-like receptors
CA2748181C (en) 2009-01-06 2019-07-16 Nathanael S. Gray Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders
DK2442809T3 (da) 2009-06-17 2016-12-19 Vertex Pharma Inhibitorer for replikation af influenzavirus
ES2661850T3 (es) 2009-09-14 2018-04-04 Gilead Sciences, Inc. Moduladores de receptores del tipo toll
AU2011343642A1 (en) 2010-12-16 2013-05-02 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
UA118010C2 (uk) 2011-08-01 2018-11-12 Вертекс Фармасьютікалз Інкорпорейтед Інгібітори реплікації вірусів грипу
EP3670515B1 (en) 2013-03-15 2024-03-06 Dana-Farber Cancer Institute, Inc. Pyrimido-diazepinone compounds and methods of treating disorders
WO2015013635A2 (en) 2013-07-25 2015-01-29 Dana-Farber Cancer Institute, Inc. Inhibitors of transcription factors and uses thereof
TWI652014B (zh) * 2013-09-13 2019-03-01 美商艾佛艾姆希公司 雜環取代之雙環唑殺蟲劑
RS57541B1 (sr) 2013-11-13 2018-10-31 Vertex Pharma Postupci za pripremu inhibitora replikacije virusa gripa
EP3068776B1 (en) 2013-11-13 2019-05-29 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
WO2015117087A1 (en) 2014-01-31 2015-08-06 Dana-Farber Cancer Institute, Inc. Uses of diazepane derivatives
EP3099677A4 (en) 2014-01-31 2017-07-26 Dana-Farber Cancer Institute, Inc. Diaminopyrimidine benzenesulfone derivatives and uses thereof
TWI733652B (zh) 2014-07-11 2021-07-21 美商基利科學股份有限公司 用於治療ＨＩＶ之ｔｏｌｌ樣受體調節劑
EP3177626A4 (en) 2014-08-08 2017-12-27 Dana Farber Cancer Institute, Inc. Diazepane derivatives and uses thereof
US9573952B2 (en) 2014-09-16 2017-02-21 Gilead Sciences, Inc. Methods of preparing toll-like receptor modulators
JP2017526730A (ja) 2014-09-16 2017-09-14 ギリアード サイエンシーズ， インコーポレイテッド Ｔｏｌｌ様受容体モジュレーターの固体形態
JP6704416B2 (ja) 2015-05-13 2020-06-03 バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ インフルエンザウイルスの複製の阻害剤を調製する方法
MA42422A (fr) 2015-05-13 2018-05-23 Vertex Pharma Inhibiteurs de la réplication des virus de la grippe
EP3307728A4 (en) 2015-06-12 2019-07-17 Dana Farber Cancer Institute, Inc. COMBINATION THERAPY OF TRANSCRIPTION INHIBITORS AND CHINESE INHIBITORS
PE20181287A1 (es) 2015-09-11 2018-08-07 Dana Farber Cancer Inst Inc Ciano tienotriazolpirazinas y usos de las mismas
UA123946C2 (uk) 2015-09-11 2021-06-30 Дана-Фарбер Кенсер Інстітьют, Інк. Ацетамідтієнотриазолодіазепіни й шляхи їх застосування
CA3003288A1 (en) 2015-11-25 2017-06-01 Dana-Farber Cancer Institute, Inc. Bivalent bromodomain inhibitors and uses thereof
US11155556B2 (en) * 2016-04-07 2021-10-26 Dana-Farber Cancer Institute, Inc. Pyrimido-diazepinone kinase scaffold compounds and methods for treating PI3K-mediated disorders
KR20220011685A (ko) 2019-05-22 2022-01-28 길리애드 사이언시즈, 인코포레이티드 Tlr7 조절 화합물과 hiv 백신의 조합
EP4034132B1 (en) 2019-09-27 2026-02-25 Dana-Farber Cancer Institute, Inc. Erk5 degraders as therapeutics in cancer and inflammatory diseases
KR20210122164A (ko) * 2020-03-27 2021-10-08 (주) 업테라 Plk1의 선택적 분해를 유도하는 벤즈이미다졸 티오펜 유도체 화합물
WO2022145989A1 (ko) * 2020-12-31 2022-07-07 (주) 업테라 선택적 plk1 억제제로서의 피리미도디아제핀 유도체
KR102604801B1 (ko) * 2021-08-10 2023-11-22 (주) 업테라 신규 plk1 분해 유도 화합물
GB202313514D0 (en) 2023-09-05 2023-10-18 Cambridge Entpr Ltd Treatment of inflammatory diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001019828A2 (en) * 1999-09-17 2001-03-22 Basf Aktiengesellschaft Kinase inhibitors as therapeutic agents
EA007062B1 (ru) 2001-09-04 2006-06-30 Бёрингер Ингельхайм Фарма Гмбх Унд Ко. Кг Новые дигидроптеридиноны, способы их получения и их применение в качестве лекарственных средств
AU2007215221C1 (en) * 2006-02-14 2013-05-30 Vertex Pharmaceuticals Incorporated Dihydrodiazepines useful as inhibitors of protein kinases
TW200808325A (en) * 2006-07-06 2008-02-16 Astrazeneca Ab Novel compounds

Also Published As

Publication number Publication date
BRPI0809088A2 (pt) 2014-09-09
EP2139892A1 (en) 2010-01-06
CL2008000785A1 (es) 2009-03-27
JP5087640B2 (ja) 2012-12-05
PE20120495A1 (es) 2012-05-12
MX2009010034A (es) 2009-10-12
SI2139892T1 (sl) 2011-12-30
PL2139892T3 (pl) 2012-03-30
IL200617A0 (en) 2010-05-17
CN101636399A (zh) 2010-01-27
KR20090119913A (ko) 2009-11-20
TW200843781A (en) 2008-11-16
TWI363629B (en) 2012-05-11
AR065794A1 (es) 2009-07-01
PT2139892E (pt) 2011-11-21
US20080234255A1 (en) 2008-09-25
EP2139892B1 (en) 2011-09-14
KR101157848B1 (ko) 2012-07-11
HK1139936A1 (en) 2010-09-30
JP2010521514A (ja) 2010-06-24
CN101636399B (zh) 2012-04-18
AU2008228303A1 (en) 2008-09-25
CN102746175A (zh) 2012-10-24
WO2008113711A1 (en) 2008-09-25
HRP20110807T1 (hr) 2011-12-31
CN102746175B (zh) 2014-01-15
ATE524472T1 (de) 2011-09-15
IL200617A (en) 2014-02-27
ES2371832T3 (es) 2012-01-10
CA2680757A1 (en) 2008-09-25
US7517873B2 (en) 2009-04-14
AU2008228303B2 (en) 2012-04-19
CY1112102T1 (el) 2015-11-04

Similar Documents

Publication Publication Date Title
DK2086939T3 (da) Pyridiacarboxamid som II-beta-HSDI-inhibitorer
CY2017016I2 (el) Αναστολεις πρωτεασωματος
HUS1900016I1 (hu) C7-fluorral helyettesített tetraciklin vegyületek
DK2383271T3 (da) Aminoquinoloner som GSK-3-inhibitorer
DK2331547T3 (da) Pyrrolopyrimidinforbindelser som CDK-inhibitorer
IL200617A0 (en) Substituted pyrimidodiazepines useful as plk1 inhibitors
DK2069324T3 (da) Fusioneret aminopyridin som hsp90-inhibitorer
DK2220070T3 (da) 2-benzylpyridazinonderivater som Met-kinaseinhibitorer
DK2421825T3 (da) Azetidinyldiamider som monoacylglycerollipase-inhibitorer
DK2125748T3 (da) Acylaminopyrazol som FGFR inhibitorer
DK2102205T3 (da) Pyridopyrazinderivater anvendelige som herbicidale forbindelser
DK2185567T3 (da) Substituerede bicyclolactam-forbindelser
DK2300465T3 (da) Imidazopyridinderivater som hæmmere af receptortyrosinkinaser
BRPI0813500A2 (pt) Compostos antivirais
DK2389382T3 (da) Aminoheterocykliske forbindelser anvendt som pde9-inhibitorer
BRPI0821086A2 (pt) Compostos inseticidas
DK2125792T3 (da) Purinderivater som immunomodulatorer
DK1926722T3 (da) Substituerede benzimidazoler som kinaseinhibitorer
DK1937671T3 (da) Benzimidazolthiophenforbindelser som PLK-inhibitorer
BRPI0918602A2 (pt) composto (i)
BRPI0811264A2 (pt) Compostos
BRPI0809996A2 (pt) Compostos
BRPI0814424A2 (pt) Compostos heterociclila
BRPI0815181A2 (pt) Compostos
EP2177529A4 (en) NEW SECRETASE HEMMER